GFPT1 and metastatic malignant neoplasm in the lymph nodes: Lymph node metastasis (P = 0.004), pTNM stage (P = 0.002), and GFAT1 expression (P < 0.001) were found to be risk factors for survival in patients with pancreatic cancer (Table 2).